Zafer A. Kaplancıklı

Eskisehir, 26470, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents.

Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents.

Journal: Molecules (Basel, Switzerland)

Published: May 29, 2026

Synthesis, Antidepressant-like and Anxiolytic-like Effects of Novel Thiadiazole Derivatives: Behavioral Assessment and Mechanistic Investigation.

Synthesis, Antidepressant-like and Anxiolytic-like Effects of Novel Thiadiazole Derivatives: Behavioral Assessment and Mechanistic Investigation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 26, 2026

Rational design and biological evaluation of naturally inspired indole-oxadiazole derivatives as potent COX inhibitors.

Rational design and biological evaluation of naturally inspired indole-oxadiazole derivatives as potent COX inhibitors.

Journal: Zeitschrift fur Naturforschung. C, Journal of biosciences

Published: March 04, 2026

Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment.

Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment.

Journal: RSC medicinal chemistry

Published: March 01, 2026

Synthesis, Anticancer Activity Evaluation, and Molecular Docking Studies of Some New Chalcone and Pyrazoline Derivatives.

Synthesis, Anticancer Activity Evaluation, and Molecular Docking Studies of Some New Chalcone and Pyrazoline Derivatives.

Journal: Chemistry & biodiversity

Published: December 29, 2025

Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New N-Heterocyclic Compounds as Aromatase Inhibitors.

Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New N-Heterocyclic Compounds as Aromatase Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 26, 2025

Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors.

Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors.

Journal: RSC advances

Published: November 10, 2025

Design, Synthesis, and Antimicrobial Evaluation of Novel Triazole-Acetamide-Linked Thiadiazole Hybrids.

Design, Synthesis, and Antimicrobial Evaluation of Novel Triazole-Acetamide-Linked Thiadiazole Hybrids.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: August 30, 2025

Latest developments in small molecule analgesics: heterocyclic scaffolds I.

Latest developments in small molecule analgesics: heterocyclic scaffolds I.

Journal: Future medicinal chemistry

Published: August 13, 2025

Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease.

Synthesis and biological evaluation of novel hydrazone derivatives for the treatment of Alzheimer's disease.

Journal: RSC advances

Published: August 06, 2025

Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors.

Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors.

Journal: RSC advances

Published: July 25, 2025

Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer.

Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 15, 2025

Showing 1-12 of 140

Last Updated: 09/26/2026